Category: New products
-
Self-Propelled Particles Designed to Stop Bleeding
2 October 2015. A biochemistry lab designed microscale particles that travel on their own through the body to stop heavy bleeding in trauma victims, surgery, and childbirth. Researchers at University of British Columbia in Vancouver, Canada led by biochemistry and engineering professor Christian Kastrup, published their findings in today’s issue of the journal Science Advances.…
-
Jet Fuel Additive Reduces Chance for Crash Explosions
2 October 2015. Materials scientists and chemists designed a polymer additive that reduces the explosive nature of jet fuel in crashes or terror attacks, without compromising the fuel’s performance. Researchers from California Institute of Technology and Jet Propulsion Laboratory in Pasadena published their findings in today’s issue of the journal Science (paid subscription required). The…
-
Manufacturing Process Devised for Skin-Patch Electronics
30 September 2015. Engineers and materials scientists designed a manufacturing process for electronic health monitors worn like tattoos that cut their production time to about 20 minutes. The team led by engineering professor Nanshu Lu at University of Texas in Austin reported its findings last week in the journal Advanced Materials (paid subscription required). Lu…
-
Full Genome Sequencing Offered for Under $1,000
29 September 2015. A genetics analysis company in Boston is offering full genomic sequencing, priced at under $1,000, for people willing to share the results with biomedical researchers. Veritas Genetics, a spin-off enterprise from Harvard Medical School, is making the offer to participants in the Personal Genome Project. Genomic sequencing reveals the order of nucleic acids, the…
-
Simpler Genome Editing Process Discovered
25 September 2015. Researchers at the Broad Institute, a biomedical research center affiliated with Harvard University and MIT, revealed a simpler and potentially more accurate technique for editing mammalian genomes than used today. The team led by biomedical engineering professor Feng Zhang, a pioneer in genomic editing technologies at Broad Institute and MIT, published its…
-
Hydrogel Aids Stem Cells Repair Heart Functions
25 September 2015. Tissue engineers and medical researchers at Johns Hopkins University developed a gel material that holds and supports the work of stem cells in repairing heart damage in lab animals. The team led by cardiologist Marie Roselle Abraham and medical materials scientist Jennifer Elisseeff published its findings earlier this month in the journal…
-
Engineered Viruses Harnessed to Fight Bacteria
24 September 2015. Researchers at Massachusetts Institute of Technology designed a new technique for fighting bacteria, by genetically engineering their natural predators, a type of virus. The team from the synthetic biology lab led by engineering professor Timothy Lu published its findings yesterday in the journal Cell Systems. Lu and colleagues are seeking a better…
-
Clinical Trial Underway Testing Cancer Surgery Aid
22 September 2015. A clinical trial is enrolling patients with soft tissue sarcoma to test a synthetic peptide that illuminates cancer cells to make them more easily removed during surgery. The early-stage study is testing the safety of the peptide made by Blaze Bioscience Inc. in Seattle and conducted at Cedars-Sinai Medical Center in Los…
-
Virus Particles Rebuilt to Boost Immunotherapies
22 September 2015. Engineers at Stanford University redesigned a hepatitis virus from the inside out to make it a better vehicle to stimulate the immune system for treating disease. The team led by chemical and bioengineering professor James Swartz published its results yesterday in Proceedings of the National Academy of Sciences (paid subscription required). Swartz…
-
Regeneron to Develop Antibody Therapy for Ebola
21 September 2015. Regeneron Pharmaceuticals Inc. received a contract from the U.S. Department of Health and Human Services to develop an engineered antibody designed to treat Ebola infections. The initial $17 million contract from HHS’s Biomedical Advanced Research and Development Authority or BARDA covers initial development and testing work on the therapy, but the program…